Intensive Couple Therapy for PTSD
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new therapy approach called AIM-CBCT for PTSD (Abbreviated, Intensive, Multi-Couple Group Cognitive-Behavioral Conjoint Therapy for PTSD), designed to assist military members and veterans with post-traumatic stress disorder. The researchers aim to determine if this therapy improves PTSD symptoms, depression, and relationship satisfaction. Participants will attend a two-day retreat to learn skills that reduce PTSD symptoms and enhance their relationships. This new therapy will be compared to a relationship education program to assess which is more effective. Service members or veterans with PTSD who have lived with their partner for at least three months might be suitable for this trial. As an unphased trial, this study provides a unique opportunity to explore innovative therapy methods that could significantly enhance well-being and relationship satisfaction.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you are currently participating in certain PTSD treatments, you may not be eligible to join the trial.
What prior data suggests that AIM-CBCT for PTSD is safe for participants?
Research shows that cognitive-behavioral conjoint therapy (CBCT) for PTSD is generally safe for participants. Studies have found that this therapy reduces PTSD symptoms and improves relationships without causing significant side effects. It helps couples work together to manage PTSD, and most find it manageable.
In past research, veterans and their partners who tried CBCT reported improvements in PTSD symptoms and relationship satisfaction. No major harmful side effects were reported, indicating that the therapy is a safe option for couples managing PTSD together.
Overall, CBCT for PTSD is a safe and effective treatment, making it a promising choice for those considering joining a clinical trial.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for PTSD because they offer a unique approach compared to standard individual therapies like prolonged exposure or cognitive processing therapy. The Abbreviated, Intensive, Multi-Couple Group Cognitive-Behavioral Conjoint Therapy (AIM-CBCT) focuses on healing within a relationship context, emphasizing the power of partnership and support in recovery. This method is delivered in a multi-couple group setting, potentially fostering a community of shared experiences and mutual encouragement. Additionally, the Prevention and Relationship Education Program (PREP) supports couples by enhancing communication and relationship skills, which can be crucial for managing PTSD symptoms together. Both approaches highlight the role of relationships in mental health, offering a fresh perspective on treatment.
What evidence suggests that AIM-CBCT for PTSD could be an effective treatment for PTSD?
Research shows that cognitive-behavioral conjoint therapy (CBCT) for PTSD reduces PTSD symptoms and improves relationships in veterans. Studies have found that working with multiple couples simultaneously can quickly enhance both personal and relationship well-being. This trial will compare the Abbreviated, Intensive, Multi-Couple Group Cognitive-Behavioral Conjoint Therapy for PTSD (AIM-CBCT for PTSD) with the Prevention and Relationship Education Program (PREP), a standard relationship education program, to determine if AIM-CBCT offers additional benefits. AIM-CBCT not only lessens PTSD symptoms but also addresses related issues like depression and stress between partners. Early results suggest improvements in couples' satisfaction and overall relationship quality.12367
Who Is on the Research Team?
Steffany J Fredman, Ph.D.
Principal Investigator
Penn State University
Are You a Good Fit for This Trial?
This trial is for military service members or veterans with PTSD and their romantic partners who are willing to participate. Couples must be married or cohabiting for at least three months, speak English, and one partner must have a confirmed PTSD diagnosis with significant symptoms.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants attend a two-day retreat for AIM-CBCT for PTSD or PREP, practicing skills to decrease PTSD symptoms and enhance relationships
Follow-up
Participants are monitored for PTSD symptoms, depression, anxiety, anger, and relationship satisfaction
What Are the Treatments Tested in This Trial?
Interventions
- Abbreviated, Intensive, Multi-Couple Group Cognitive-Behavioral Conjoint Therapy for PTSD
- Prevention and Relationship Education Program
Abbreviated, Intensive, Multi-Couple Group Cognitive-Behavioral Conjoint Therapy for PTSD is already approved in United States, European Union for the following indications:
- Posttraumatic Stress Disorder (PTSD)
- Improvement of relationship functioning in couples where one partner has PTSD
- Posttraumatic Stress Disorder (PTSD)
- Improvement of relationship functioning in couples where one partner has PTSD
Find a Clinic Near You
Who Is Running the Clinical Trial?
Penn State University
Lead Sponsor
University of Denver
Collaborator
Toronto Metropolitan University
Collaborator
The University of Texas Health Science Center at San Antonio
Collaborator